Afya (NASDAQ:AFYA) Releases Quarterly Earnings Results, Misses Estimates By $0.01 EPS

Key Points

• Afya reported quarterly EPS of $0.36, missing the $0.37 consensus by $0.01; revenue was $190.16 million, slightly below the $190.28 million estimate.
• The company posted a 20.55% net margin and 17.58% return on equity. Shares fell $0.40 to $10.33 after the results.
• Analyst opinions remain mixed: Afya has a consensus Hold rating and an average price target of $15.18.

Afya (NASDAQ:AFYA - Get Free Report) announced its earnings results on Wednesday. The company reported $0.36 earnings per share for the quarter, missing the consensus estimate of $0.37 by ($0.01), FiscalAI reports. Afya had a net margin of 20.55% and a return on equity of 17.58%. The firm had revenue of $190.16 million during the quarter, compared to analyst estimates of $190.28 million.

Afya Price Performance

Shares of AFYA traded down $0.40 on Thursday, hitting $10.33. The company's stock had a trading volume of 190,651 shares, compared to its average volume of 191,277. The company has a debt-to-equity ratio of 0.39, a current ratio of 2.20 and a quick ratio of 2.20. The company has a market capitalization of $968.16 million, a PE ratio of 6.30, a PEG ratio of 1.69 and a beta of 0.43. The company has a 50 day moving average price of $13.00 and a 200 day moving average price of $14.05. Afya has a fifty-two week low of $9.66 and a fifty-two week high of $16.16.

Analyst Ratings Changes

A number of research analysts recently commented on AFYA shares. Bradesco Corretora raised Afya to an "outperform" rating and set a $17.00 price target for the company in a report on Thursday, September 24th. Wall Street Zen upgraded shares of Afya from a "hold" rating to a "buy" rating in a research note on Sunday. Morgan Stanley upgraded shares of Afya from an "underweight" rating to an "equal weight" rating and set a $12.60 target price for the company in a report on Thursday, November 5th. Weiss Ratings downgraded Afya from a "hold (c-)" rating to a "sell (d+)" rating in a report on Thursday, October 29th. Finally, Citigroup raised Afya from a "neutral" rating to a "buy" rating and dropped their price target for the company from $16.00 to $12.00 in a research report on Tuesday, November 3rd. Four investment analysts have rated the stock with a Buy rating, three have issued a Hold rating and two have given a Sell rating to the company. According to MarketBeat.com, the company currently has a consensus rating of "Hold" and an average target price of $15.18.

Insider Activity

In related news, insider Santos Welder Ferreira sold 4,161 shares of Afya stock in a transaction dated Monday, October 5th. The stock was sold at an average price of $13.30, for a total value of $55,341.30. Following the completion of the sale, the insider directly owned 35,000 shares in the company, valued at $465,500. This trade represents a 10.63% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Insiders own 0.80% of the company's stock.

About Afya

Afya Limited is a Brazilian medical education and digital health company. Its education business offers undergraduate medical degree programs, medical residency preparation, postgraduate courses and continuing education for health professionals. The company also provides digital tools and services for medical students and practicing physicians, including clinical reference, practice-management and learning resources. These offerings support professionals at different stages of their medical careers.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.